Public Health On Call Bonus Episode - Mifepristone and EMTALA SCOTUS Rulings: A Holding Pattern
The Supreme Court has issued decisions in the two major abortion cases on its docket this year. For the time being, the drug mifepristone remains on the market and a federal law requiring that emergency rooms provide life-saving abortions even in states banning the procedure is upheld. But the court's decisions—both upholding the status quo—all but guarantee both cases will be back, putting mifepristone and EMTALA once again under fire.
Guests:Joanne Rosen is an expert in public health law and a co-director of the Center for Law and the Public's Health at the Johns Hopkins Bloomberg School of Public Health.
Host:Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department.
Show links and related content:-
The Two Major Abortion Cases Coming to The Supreme Court—Public Health On Call
-
Despite Supreme Court ruling, the future of emergency abortions is still unclear for US women—ABC News
-
OB-GYN Training and Practice in Dobbs' Shadow–Hopkins Bloomberg Public Health Magazine
-
The Threat to Abortion Rights You Haven't Heard Of—Johns Hopkins Bloomberg School of Public Health
Have a question about something you heard? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us: